Life Science Angel Network
Dr. Milena Adamian, Director, Life Science Angel Network
ABSTRACT
Life Science Angel Network (LSAN) was built with the premise of creating an ecosystem in the
entrepreneurial and investment communities in the life sciences sector in NYC. We achieve our goal by:
bridging a gap in the early stage funding in healthcare space; building strong network of entrepreneurs,
investors, corporate players , i.e. all parties involved in the process of innovation in life sciences.
LSAN philosophy: We follow a traditional model of building innovative and profitable companies, provide
them with financial and operational support, sector-specific mentorship and access to a broad network of
healthcare investors, key opinion leaders, corporate players and entrepreneurs.
LSAN’s distinctive and unique features are: strong domain expertise in healthcare with its multidisciplinary Screening Committee, full-time professional management, access to funding sources
(syndication & non-dilutive financing), and alliances with strategic development and exit partners.
LSAN is geographically agnostic and invests in promising healthcare start-ups across the USA.
LSAN was founded in the fall of 2010 at the NY Academy of Sciences and spun off in an independent
organization in the January of 2012.
BIOGRAPHY
Dr. Adamian brings unique perspective of a clinician and academic researcher with genuine passion for
breakthrough technologies enriched by industry knowledge, Wall Street, and venture capital experience.
Milena spent last 15 years on various side of the medical device development:
Interventional Cardiology, Lenox Hill Hospital (NYC) and Columbus Hospital (Milan, Italy)
Medical Director, Taxus DES Program, Boston Scientific
Equity analyst, Medical Devices and Supplies, Lehman Brothers
Managing Director, Life Sciences, Easton Capital
Milena continues her involvement at Life Science Angels (Palo Alto, CA) and HealthTech Capital
(Palo Alto, CA).
Dr. Adamian holds a MSc degree in Biostatistics and Clinical Research Methods from Mailman School of
Public Health at Columbia University, and MD and PhD degrees in Clinical Cardiology from Russian
Academy of Medical Sciences.